trenbolone acetate has been researched along with Adenoma, Prostatic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borsa, PA; Borst, SE; Conover, CF; Conrad, BP; Johnson, SE; Kristinsson, HG; McCoy, SC; Pingel, JE; Tillman, MD; Wronski, TJ; Yarrow, JF; Ye, F | 1 |
1 other study(ies) available for trenbolone acetate and Adenoma, Prostatic
| Article | Year |
|---|---|
17β-Hydroxyestra-4,9,11-trien-3-one (Trenbolone) preserves bone mineral density in skeletally mature orchiectomized rats without prostate enlargement.
Topics: Anabolic Agents; Androgens; Animals; Biomarkers; Biomechanical Phenomena; Body Weight; Bone Density; Femur; Hemoglobins; Kidney; Male; Orchiectomy; Organ Size; Prostatic Hyperplasia; Rats; Rats, Inbred F344; Trenbolone Acetate | 2012 |